APA (7th ed.) Citation

D, A., V, R. D., N, P., & R, P. (2025). Nitrosamine Drug Substance-Related Impurities (NDSRIs) in Pharmaceuticals: Formation, Mitigation Strategies, and Emphasis on Mutagenicity Risks. Pharmaceutical research, 42(4), 547. https://doi.org/10.1007/s11095-025-03857-9

Chicago Style (17th ed.) Citation

D, Aishwarya, Ramakant Dhampalwar V, Pallaprolu N, and Peraman R. "Nitrosamine Drug Substance-Related Impurities (NDSRIs) in Pharmaceuticals: Formation, Mitigation Strategies, and Emphasis on Mutagenicity Risks." Pharmaceutical Research 42, no. 4 (2025): 547. https://doi.org/10.1007/s11095-025-03857-9.

MLA (9th ed.) Citation

D, Aishwarya, et al. "Nitrosamine Drug Substance-Related Impurities (NDSRIs) in Pharmaceuticals: Formation, Mitigation Strategies, and Emphasis on Mutagenicity Risks." Pharmaceutical Research, vol. 42, no. 4, 2025, p. 547, https://doi.org/10.1007/s11095-025-03857-9.